Drug intelligence / Profile preview

TBF demineralized bone matrix

Development stage
Unknown
Lead developer
TBF Génie Tissulaire
Administration
Surgical Implantation
01

Overview

TBF demineralized bone matrix (DBM) is a human allograft biologic material developed by TBF Genie Tissulaire, a French biotechnology company and tissue bank. Derived from human allogeneic bone tissue obtained from living donors, the product is processed into powders and fibers for surgical use. It functions as an osteoconductive and osteoinductive scaffold, providing a collagenous matrix and endogenous growth factors (such as bone morphogenetic proteins) that facilitate bone regeneration and repair. It is primarily indicated for maxillofacial reconstruction, dental reconstruction, and oral and maxillofacial surgery to fill bony voids or gaps. The product is authorized by the French National Agency for the Safety of Medicines and Health Products (ANSM) and is administered via surgical implantation.

Other names
demineralized bone matrix allograftbiologic graft materialbone powdersDBM fibers
02

Targets

BMPR (Bone morphogenetic protein receptor)TGFBR (TGF-beta receptor)

Beyond the preview

Go deeper on TBF demineralized bone matrix.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on TBF demineralized bone matrix.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call